Research ArticleClinical Investigations
Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer
Saila Kauhanen, Camilla Schalin-Jäntti, Marko Seppänen, Sami Kajander, Sami Virtanen, Jukka Schildt, Irina Lisinen, Aapo Ahonen, Ilkka Heiskanen, Mika Väisänen, Johanna Arola, Pirkko Korsoff, Tapani Ebeling, Timo Sane, Heikki Minn, Matti J. Välimäki and Pirjo Nuutila
Journal of Nuclear Medicine December 2011, 52 (12) 1855-1863; DOI: https://doi.org/10.2967/jnumed.111.094771
Saila Kauhanen
Camilla Schalin-Jäntti
Marko Seppänen
Sami Kajander
Sami Virtanen
Jukka Schildt
Irina Lisinen
Aapo Ahonen
Ilkka Heiskanen
Mika Väisänen
Johanna Arola
Pirkko Korsoff
Tapani Ebeling
Timo Sane
Heikki Minn
Matti J. Välimäki

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 52, Issue 12
December 1, 2011
Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer
Saila Kauhanen, Camilla Schalin-Jäntti, Marko Seppänen, Sami Kajander, Sami Virtanen, Jukka Schildt, Irina Lisinen, Aapo Ahonen, Ilkka Heiskanen, Mika Väisänen, Johanna Arola, Pirkko Korsoff, Tapani Ebeling, Timo Sane, Heikki Minn, Matti J. Välimäki, Pirjo Nuutila
Journal of Nuclear Medicine Dec 2011, 52 (12) 1855-1863; DOI: 10.2967/jnumed.111.094771
Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer
Saila Kauhanen, Camilla Schalin-Jäntti, Marko Seppänen, Sami Kajander, Sami Virtanen, Jukka Schildt, Irina Lisinen, Aapo Ahonen, Ilkka Heiskanen, Mika Väisänen, Johanna Arola, Pirkko Korsoff, Tapani Ebeling, Timo Sane, Heikki Minn, Matti J. Välimäki, Pirjo Nuutila
Journal of Nuclear Medicine Dec 2011, 52 (12) 1855-1863; DOI: 10.2967/jnumed.111.094771
Jump to section
Related Articles
Cited By...
- Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
- False-positive findings on 6-[18F]fluor-L-3,4-dihydroxyphenylalanine PET (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors
- Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial
- ENDOCRINE TUMOURS: Progressive metastatic medullary thyroid carcinoma: first- and second-line strategies
- Relevance of Calcitonin Cut-off in the Follow-up of Medullary Thyroid Carcinoma for Conventional Imaging and 18-Fluorine-Fluorodihydroxyphenylalanine PET
- Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma